Abstract
Treatment with the fibrinolytic inhibitor tranexamic acid was investigated in 12 women with vaginal bleeding in the second half of pregnancy. The aim of the therapy was to accelerate haemostasis in the uteroplacental circulation and to prevent further bleeding at the placental site. Tranexamic acid 1 g 8-hourly was given for 7 days. Serial investigations of coagulation and fibrinolysis were carried out. Plasma fibrinolytic activity, plasminogen, antiplasmin and platelet count significantly decreased during treatment, while antithrombin III and factor VIII related antigen showed a significant increase. Plasma tranexamic acid levels ranged from 5 mg/1 to 17 mg/1. Two patients on treatment at the time of delivery had plasma tranexamic acid levels of 9 mg/1 and 12 mg/1 detected in the umbilical cord venous blood. No adverse effects were detected in any of the mothers and all 12 were delivered of live born infants. Tranexamic acid may have a therapeutic role in accelerating haemostasis in the uteroplacental circulation and thereby reducing the adverse effects of bleeding at the placental site.
Key words
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Andersson L, Nilsson IM, Nilehn J-E, Hedner U, Grandstand B, Melander B (1965) Experimental and clinical studies on AMCA, the antifibrinolytically active isomer of p-amionmethyl cyclohexane carboxylic acid. Scand J Haematol 2: 230–247
Biggs R, Eveling J, Richards G (1955) The assay of antihaemophilic globulin activity. Br J Haematol 1: 20
Bonnar J (1978) Haemostatic function and coagulopathy during pregnancy. In: Wynn RM (ed) Obstetrics and gynecology annual, vol 7. Appleton-Century-Crofts, New York, pp 195–217
Clauss A (1957) Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 17: 237
Collen D, Tytgat G, Claeys H, Verstraete M, Wallen P (1972a) Metabolism of plasminogen in healthy subjects: effect of tranexamic acid. J Clin Invest 51: 1310–1318
Collen D, Tytgat GN, Claeys H, Piessens R (1972b) Metabolism and distribution of fibrinogen. I. Fibrinogen turnover in physiological conditions in humans. Br J Haematol 22: 681–700
Cultrera G, Lampugnani P (1973) Fibrinogen-Turnover nach Verabreichung von Hirnphospholipiden in Kombination mit einem Antifibrinolytikum ( AMCHA ). Arzneim Forsch 23: 445–447
Hoylaerts M, Lijnen HR, Collen D (1981) Studies on the mechanism of the antifibrinolytic action of tranexamic acid. Biochim Biophys Acta 673: 75–85
Kluft C, Brakman P, Veldhuyzen-Stolk EC (1976) Screening of fibrinolytic activity in plasma euglobulin fractions on the fibrin plate. In: Davidson JF, Samama MM, Desnoyers PC (eds) Progress in chemical fibrinolysis and thrombolysis, vol 2. Ravens Press, New York
Laurell CB (1966) Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 15: 45
Pilbrant A, Schannong M, Vessman J (1981) Pharmacokinetics and bioavailability of tranexamic acid. Eur J Clin Pharmacol 20: 65–72
Poller L, Thomson JM, Sear CHJ, Thomas W (1971) Identification of a congenital defect of factor VII in a colony of beagle dogs: the chemical use of the plasma J Clin Pathol 24: 626
Sheppard BL, Bonnar J (1974) The ultrastructure of the arterial supply of the human placenta in early and late pregnancy. J Obstet Gynaecol Br Commonw 81: 497–511
Sheppard BL, Bonnar J (1978) Fibrinolysis in decidual spiral arteries in late pregnancy. Thromb Haemostasis 39: 751–757
Spragg J (1978) Specific functional and immunologic assay of plasma plasminogen in hereditary angioedema treated with tranexamic acid, and in normal subjects. J Immunol 120: 592–596
Thomson J (1980) Blood coagulation and haemostasis: a practical guide. Churchill Livingstone, Edinburgh London New York
Todd AS (1959) Histological localization of fibrinolysis activator. J Pathol Bacteriol 78: 281–283
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Springer-Verlag
About this paper
Cite this paper
Walzman, M., Bonnar, J. (1982). Effects of Tranexamic Acid on the Coagulation and Fibrinolytic Systems in Pregnancy Complicated by Placental Bleeding. In: Chambers, C.M., Chambers, P.L. (eds) New Toxicology for Old. Archives of Toxicology, vol 5. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68511-8_39
Download citation
DOI: https://doi.org/10.1007/978-3-642-68511-8_39
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-11406-2
Online ISBN: 978-3-642-68511-8
eBook Packages: Springer Book Archive